CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
111 hedge funds and large institutions have $255M invested in Concert Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
111
Holders Change
-9
Holders Change %
-7.5%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
42
Reduced
40
Closed
15
Calls
$331K
Puts
$583K
Net Calls
-$252K
Net Calls Change
-$252K
Top Buyers
1 |
First Manhattan
New York
|
$8.38M |
2 |
Dimensional Fund Advisors
Austin,
Texas
|
$15.9M |
3 |
Renaissance Technologies
New York
|
$10.8M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
$18.2M |
5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
$1.35M |